These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33796992)

  • 1. Nonalcoholic Fatty Liver Disease and Subclinical Hypothyroidism in Obese Children.
    Sharma R
    Indian J Pediatr; 2021 May; 88(5):425-426. PubMed ID: 33796992
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism.
    Feysa SV; Chopei IV
    Wiad Lek; 2019; 72(4):650-653. PubMed ID: 31055550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
    Chun HS; Lee M
    Clin Mol Hepatol; 2023 Apr; 29(2):377-380. PubMed ID: 36907573
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents.
    Kaltenbach TE; Graeter T; Oeztuerk S; Holzner D; Kratzer W; Wabitsch M; Denzer C
    Pediatr Obes; 2017 Feb; 12(1):67-74. PubMed ID: 26877190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children.
    Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A
    Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
    Han E; Lee YH
    Clin Mol Hepatol; 2023 Oct; 29(4):980-983. PubMed ID: 37584065
    [No Abstract]   [Full Text] [Related]  

  • 9. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders.
    Feisa SV; Chopei IV
    Wiad Lek; 2018; 71(2 pt 1):261-264. PubMed ID: 29729151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk of Developing Non-Alcoholic Fatty Liver Disease in Adult Patients with Subclinical Hypothyroidism Compared to Euthyroid: An Evidence-based Case Report.
    Notariza KR; Wisnu W
    Acta Med Indones; 2019 Apr; 51(2):179-188. PubMed ID: 31383835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the Triglyceride Glucose Index to Predict Nonalcoholic Fatty Liver Disease in Children With Obesity.
    Chang PS; Chang PF; Lin YC
    J Pediatr; 2023 Apr; 255():260-261. PubMed ID: 36535409
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
    Zhaldak DA; Melekhovets OK; Orlovskyi VF
    Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ; Yi DY; Yang HR
    J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to the Letter to the Editor on "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children".
    Zhang J
    Horm Metab Res; 2024 Jun; 56(6):472. PubMed ID: 38698580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis.
    Kwon YD; Ko KO; Lim JW; Cheon EJ; Song YH; Yoon JM
    J Korean Med Sci; 2019 Jun; 34(23):e165. PubMed ID: 31197983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
    Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X
    BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
    Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD
    Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence of endobariatrics and endohepatology for evaluation and treatment of obesity and nonalcoholic fatty liver disease.
    Krishnan A; Shah-Khan SM; Hadi Y; Thakkar S; Singh S
    Endoscopy; 2023 Dec; 55(S 01):E841-E843. PubMed ID: 37369246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.